Your Search Returned 188 tagged news reports
Drug discovery is the process by which novel therapeutic candidates are discovered and ultimately developed into human-grade medications. These candidates may include compounds ranging from modified or unmodified natural products or extracts and
Tags:
Our initial focus on CNS soon spanned into many other medical specialties and our group grew solid by incorporating some of the people with most clinical trial experience in the region. ONE technology with local industry experts to create a superior
Tags:
Despite the pleas of her parents, doctors and politicians, Chloe Drury was refused access to treatment being trialled by American pharmaceutical company BioMarin. Her family says she was told last September, when she was 17, that she was too young to
Tags:
Theravance to split into drug development, royalty companies Theravance CEO Rick Winningham would lead both the royalty management company and drug development company. Ahead of FDA approval of its two inhaled lung drugs, Theravance Inc. said
Tags:
Presented by the Institute for International Research and Partnerships in Clinical Trials' advisory board, the award recognises two or more companies engaged in a partnership that moves beyond the traditional transactional model to a more strategic
Tags:
The company was founded in 1988, back in the very earliest flush of the Combichem era, and in its early years it (along with Pharmacopeia) was what people thought of when they thought of that whole approach...If you weren't around for it, you'll have
Tags:
Here he is at a recent conference in London when the topic of drug pricing came up: . . . Witty said the $1 billion price tag was "one of the great myths of the industry", since it was an average figure that includes money spent on drugs that
Tags:
Cash and cash equivalents balance of $25.7 million as of December 31, 2012. Full Year 2012 Highlights: Milestone revenues of $20.0 million for year end 2012. Royalty revenues of $20.5 million, an increase of $16.0 million (357%) from year end 2011.
Tags:
It continues his earlier theme of scaling back Phase III trials (which I commented on here )...Today, in an era of precision or personalized-drug development, when medicines increasingly work for very specific patient groups, the system may be
Tags:
The ongoing handwringing over ways to improve clinical trial productivity can reveal any number of issues that call for improvement. One key area, however, may be the interplay between drugmakers and their contract research organizations which, of
Tags: